ag-1296 has been researched along with Sarcoma 180 in 1 studies
6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase
Sarcoma 180: An experimental sarcoma of mice.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakagawa, H | 1 |
| Koyanagi, S | 1 |
| Kuramoto, Y | 1 |
| Yoshizumi, A | 1 |
| Matsunaga, N | 1 |
| Shimeno, H | 1 |
| Soeda, S | 1 |
| Ohdo, S | 1 |
1 other study available for ag-1296 and Sarcoma 180
| Article | Year |
|---|---|
Modulation of circadian rhythm of DNA synthesis in tumor cells by inhibiting platelet-derived growth factor signaling.
Topics: Animals; Bone Marrow Cells; Cell Proliferation; Circadian Rhythm; Disease Progression; DNA; Gene Exp | 2008 |